STLN — Starling Oncology, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1799191 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 99,901,000 | 128,120,000 | -13,853,000 | -16,113,000 | 172,717,000 | — | 169,128,000 |
| Dec 2023 | 82,035,000 | 111,915,000 | -13,925,000 | -17,419,000 | 209,240,000 | — | 152,215,000 |
| Dec 2022 | 60,921,000 | 79,567,000 | -18,304,000 | -5,453,000 | 261,665,000 | — | 138,490,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$328,000
Investing CF
$-3,614,000
Financing CF
$14,088,000
CapEx
$-3,614,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.30
As of
2026-08-16
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 393,412,000 | -60,118,000 | -64,663,000 | 172,717,000 | 169,128,000 | — | — |
| Dec 2023 | 324,239,000 | -77,018,000 | -83,068,000 | 209,240,000 | 152,215,000 | — | — |
TTM Snapshot
Revenues TTM
$363,872,000
NetIncome TTM
$-67,064,000
OpCashFlow TTM
$0
Assets (Latest)
$172,717,000
Forward EPS
—
Max Pain — expiry 2026-08-21
max pain strike: $4.00 · spot: $6.45 · call oi: 7,591 · put oi: 880
Expected Move to 2026-08-21:
±$0.67
(10.39%) —
implied range
$5.78 –
$7.12
· ATM straddle on $6.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HCA | HCA Healthcare, Inc. | $89.77B | $404.68 | — |
| NTRA | Natera, Inc. | $44.67B | $309.93 | — |
| DGX | QUEST DIAGNOSTICS INC | $25.87B | $234.40 | — |
| LH | LABCORP HOLDINGS INC. | $25.80B | $318.13 | — |
| THC | TENET HEALTHCARE CORP | $21.57B | $267.90 | — |
Recent Insider Activity
No insider activity indexed for this ticker.